Regenxbio Inc (RGNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: RGNX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-10-02	2024-10-01	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	10,000 -47.0% 10.11 USD 101,052	10,000 -47.0%	10.11	USD 101,052
2024-09-04	2024-09-03	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	700 -5.8% 12.34 USD 8,638	700 -5.8%	12.34	USD 8,638
2024-09-04	2024-09-03	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	9,300 -43.7% 11.50 USD 106,950	9,300 -43.7%	11.50	USD 106,950
2024-08-05	2024-08-01	PS Planned sale	Simpson Curran Chief Executive Officer Executive Director	100 -0.1% 15.00 USD 1,500	100 -0.1%	15.00	USD 1,500
2024-08-05	2024-08-01	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	100 -0.9% 15.00 USD 1,500	100 -0.9%	15.00	USD 1,500
2024-08-05	2024-08-01	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	400 -3.4% 14.59 USD 5,834	400 -3.4%	14.59	USD 5,834
2024-08-05	2024-08-01	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	9,600 -44.9% 13.45 USD 129,120	9,600 -44.9%	13.45	USD 129,120
2024-07-30	2024-07-29	PS Planned sale	Simpson Curran Chief Executive Officer Executive Director	9,648 -5.4% 15.04 USD 145,106	9,648 -5.4%	15.04	USD 145,106
2024-07-30	2024-07-29	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	11,000 -49.4% 15.05 USD 165,495	11,000 -49.4%	15.05	USD 165,495
2024-07-26	2024-07-25	PS Planned sale	Mills Kenneth T. Non-Executive Director	15,369 -3.6% 13.96 USD 214,501	15,369 -3.6%	13.96	USD 214,501
2024-07-26	2024-07-24	PS Planned sale	Mills Kenneth T. Non-Executive Director	12,221 -2.9% 13.78 USD 168,433	12,221 -2.9%	13.78	USD 168,433
2024-07-18	2024-07-17	PS Planned sale	Mills Kenneth T. Non-Executive Director	2,210 -0.5% 13.77 USD 30,440	2,210 -0.5%	13.77	USD 30,440
2024-07-18	2024-07-16	PS Planned sale	Mills Kenneth T. Non-Executive Director	200 -0.0% 13.76 USD 2,752	200 -0.0%	13.76	USD 2,752
2024-07-03	2024-07-01	PS Planned sale	KARABELAS ARGERIS N Non-Executive Director	10,000 -47.0% 11.27 USD 112,691	10,000 -47.0%	11.27	USD 112,691
2024-05-16	2024-05-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -3.5% 15.81 USD 237,222	15,000 -3.5%	15.81	USD 237,222
2024-04-17	2024-04-15	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -3.5% 18.19 USD 272,871	15,000 -3.5%	18.19	USD 272,871
2024-03-18	2024-03-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -3.5% 21.86 USD 327,942	15,000 -3.5%	21.86	USD 327,942
2024-03-07	2024-03-05	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	12,878 -10.7% 28.36 USD 365,220	12,878 -10.7%	28.36	USD 365,220
2024-02-16	2024-02-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	10,348 -2.5% 16.88 USD 174,723	10,348 -2.5%	16.88	USD 174,723
2024-02-16	2024-02-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,652 -1.1% 16.47 USD 76,626	4,652 -1.1%	16.47	USD 76,626
2024-01-18	2024-01-16	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	45,000 -9.9% 15.18 USD 682,992	45,000 -9.9%	15.18	USD 682,992
2024-01-04	2024-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	17,237 -13.9% 17.39 USD 299,789	17,237 -13.9%	17.39	USD 299,789
2023-12-21	2023-12-19	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	45,000 -11.2% 19.69 USD 885,825	45,000 -11.2%	19.69	USD 885,825
2023-01-05	2023-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	3,138 -20.5% 22.17 USD 69,559	3,138 -20.5%	22.17	USD 69,559
2022-08-31	2022-08-30	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,400 -1.7% 30.24 USD 72,573	2,400 -1.7%	30.24	USD 72,573
2022-08-08	2022-08-05	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	17,280 -11.2% 35.19 USD 608,035	17,280 -11.2%	35.19	USD 608,035
2022-08-08	2022-08-04	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	400 -0.3% 35.00 USD 14,000	400 -0.3%	35.00	USD 14,000
2022-08-03	2022-08-01	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,400 -1.5% 31.26 USD 75,012	2,400 -1.5%	31.26	USD 75,012
2022-07-15	2022-07-14	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	468 -0.3% 30.00 USD 14,040	468 -0.3%	30.00	USD 14,040
2022-07-15	2022-07-13	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	4,332 -2.7% 30.01 USD 129,988	4,332 -2.7%	30.01	USD 129,988
2022-01-04	2022-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	1,598 -16.2% 33.75 USD 53,933	1,598 -16.2%	33.75	USD 53,933
2021-11-10	2021-11-08	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.00 USD 60,000	1,500 -0.5%	40.00	USD 60,000
2021-09-29	2021-09-27	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 42.19 USD 63,285	1,500 -0.5%	42.19	USD 63,285
2021-06-28	2021-06-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.25 USD 60,375	1,500 -0.5%	40.25	USD 60,375
2021-06-28	2021-06-24	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.6% 40.02 USD 180,090	4,500 -1.6%	40.02	USD 180,090
2021-03-01	2021-02-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.77 USD 61,155	1,500 -0.5%	40.77	USD 61,155
2021-02-17	2021-02-12	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,701 -22.3% 49.08 USD 230,725	4,701 -22.3%	49.08	USD 230,725
2021-02-10	2021-02-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,300 -7.4% 49.11 USD 63,843	1,300 -7.4%	49.11	USD 63,843
2021-02-04	2021-02-02	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	500 -3.0% 45.13 USD 22,565	500 -3.0%	45.13	USD 22,565
2021-02-04	2021-02-02	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	9,500 -36.0% 44.77 USD 425,315	9,500 -36.0%	44.77	USD 425,315
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	5,211 -1.8% 44.99 USD 234,443	5,211 -1.8%	44.99	USD 234,443
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	974 -0.3% 44.05 USD 42,905	974 -0.3%	44.05	USD 42,905
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	315 -0.1% 42.64 USD 13,432	315 -0.1%	42.64	USD 13,432
2021-01-20	2021-01-15	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	252 -0.2% 50.04 USD 12,610	252 -0.2%	50.04	USD 12,610
2021-01-14	2021-01-14	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	11,093 -8.9% 50.03 USD 554,983	11,093 -8.9%	50.03	USD 554,983
2021-01-14	2021-01-14	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	11,612 -39.6% 50.01 USD 580,716	11,612 -39.6%	50.01	USD 580,716
2021-01-14	2021-01-12	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	1,700 -8.7% 50.03 USD 85,051	1,700 -8.7%	50.03	USD 85,051
2021-01-14	2021-01-12	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	4,200 -3.3% 50.01 USD 210,042	4,200 -3.3%	50.01	USD 210,042
2021-01-12	2021-01-12	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,378 -7.8% 49.15 USD 67,729	1,378 -7.8%	49.15	USD 67,729
2021-01-12	2021-01-11	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	10,122 -38.2% 49.08 USD 496,788	10,122 -38.2%	49.08	USD 496,788
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,320 -7.5% 48.13 USD 63,532	1,320 -7.5%	48.13	USD 63,532
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,062 -18.7% 47.42 USD 192,620	4,062 -18.7%	47.42	USD 192,620
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,618 -17.5% 46.43 USD 214,414	4,618 -17.5%	46.43	USD 214,414
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	573 -0.4% 48.15 USD 27,590	573 -0.4%	48.15	USD 27,590
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,208 -1.7% 47.49 USD 104,858	2,208 -1.7%	47.49	USD 104,858
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,460 -1.8% 46.45 USD 114,267	2,460 -1.8%	46.45	USD 114,267
2021-01-11	2021-01-07	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	5,185 -22.6% 50.01 USD 259,302	5,185 -22.6%	50.01	USD 259,302
2021-01-11	2021-01-07	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 50.01 USD 75,015	1,500 -0.5%	50.01	USD 75,015
2021-01-11	2021-01-07	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	10,998 -7.6% 50.00 USD 549,900	10,998 -7.6%	50.00	USD 549,900
2020-12-30	2020-12-28	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,853 -0.8% 49.16 USD 91,093	1,853 -0.8%	49.16	USD 91,093
2020-12-30	2020-12-28	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,647 -1.9% 48.47 USD 225,240	4,647 -1.9%	48.47	USD 225,240
2020-12-28	2020-12-24	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	3,376 -2.5% 50.00 USD 168,800	3,376 -2.5%	50.00	USD 168,800
2020-12-28	2020-12-23	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.8% 50.00 USD 225,000	4,500 -1.8%	50.00	USD 225,000
2020-12-28	2020-12-23	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	21,124 -13.4% 50.01 USD 1,056,411	21,124 -13.4%	50.01	USD 1,056,411
2020-12-18	2020-12-16	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -5.9% 45.00 USD 675,000	15,000 -5.9%	45.00	USD 675,000
2020-12-14	2020-12-11	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	14,916 -8.6% 40.17 USD 599,176	14,916 -8.6%	40.17	USD 599,176
2020-12-14	2020-12-10	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.8% 40.00 USD 180,000	4,500 -1.8%	40.00	USD 180,000
2020-12-14	2020-12-10	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	22,584 -11.6% 40.06 USD 904,715	22,584 -11.6%	40.06	USD 904,715
2020-07-17	2020-07-15	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	14,950 -7.1% 40.10 USD 599,495	14,950 -7.1%	40.10	USD 599,495
2020-05-12	2020-05-11	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	500 -0.2% 40.00 USD 20,000	500 -0.2%	40.00	USD 20,000
2020-05-12	2020-05-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	7,000 -3.3% 40.18 USD 281,260	7,000 -3.3%	40.18	USD 281,260
2020-04-27	2020-04-24	PS Planned sale	Vasista Vittal Chief Financial Officer	12,000 -5.4% 40.11 USD 481,320	12,000 -5.4%	40.11	USD 481,320
2020-04-27	2020-04-23	PS Planned sale	Vasista Vittal Chief Financial Officer	3,000 -1.3% 40.00 USD 120,000	3,000 -1.3%	40.00	USD 120,000
2020-02-12	2020-02-11	PS Planned sale	Simpson Curran SVP, Product Development & CTO	3,692 -48.3% 51.37 USD 189,658	3,692 -48.3%	51.37	USD 189,658
2020-02-12	2020-02-11	PS Planned sale	Simpson Curran SVP, Product Development & CTO	8,872 -53.7% 50.13 USD 444,753	8,872 -53.7%	50.13	USD 444,753

Regenxbio Inc (RGNX)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by